BOSTON SCIENTIFIC CORP — Director's Dealing 2015

Jul 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-07-01

Reporting Person: MACMILLAN STEPHEN P (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-01	Deferred Stock Units	$	A	421.0000	Acquired		Common Stock (421.0000)	Direct
2015-07-01	Stock Option (Right to Buy)	$17.8000	A	1315.0000	Acquired	2025-07-01	Common Stock (1315.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Reflects a value of $7,500 divided by the closing price of common stock on the date of grant.

F3: Deferred stock units were granted in lieu of half of the quarterly cash compensation, prorated for the time period from the Company's 2015 annual meeting of stockholders to June 30, 2015, and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

F4: Reporting person elected to receive half, or $7,500, of the quarterly cash compensation, which is prorated for the time period from the Company's 2015 annual meeting of stockholders to June 30, 2015, in the form of an option to purchase a specified number of shares of common stock vesting in full upon the next annual meeting of stockholders.